Latest Breaking News On - Post finasteride syndrome foundation - Page 1 : vimarsana.com

Another Favorable Post-Albrecht MDL Preemption Decision

Pfaff is a straggler from the In re Propecia (Finasteride) Products Liability Litigation MDL, most of which settled in 2019. The plaintiffs in Pfaff…

FDA requires disclosure of suicide risk for anti-baldness drug

U.S. health regulators rejected a request to remove popular anti-baldness pill Propecia and its generic versions from the market, but for the first time required patient notification about reports of suicidal behavior in men taking the drug.

FDA requires disclosure of suicide risk for anti-baldness drug

By Dan Levine

FDA requires disclosure of suicide risk for anti-baldness drug

By Dan Levine (Reuters) - U.S. health regulators rejected a request to remove popular anti-baldness pill Propecia and its generic versions from the ma.

Lawsuit Brings Renewed Attention to Finasteride Adverse Events